100+ Free ABOG Urogynecology and Reconstructive Pelvic Surgery Practice Questions

Pass your ABOG Urogynecology and Reconstructive Pelvic Surgery Subspecialty Certifying Examination exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

~85-92% Pass Rate

100+ Questions

100% Free

1 / 100

Question 1

Score: 0/0

A 58-year-old postmenopausal woman presents with urinary leakage with coughing, laughing, and exercise. She has no urgency symptoms. Urinalysis is normal, PVR is 30 mL. What is the most likely diagnosis?

Overactive bladder with urgency urinary incontinence

Stress urinary incontinence

Overflow incontinence

Functional incontinence

to track

2026 Statistics

Key Facts: ABOG Urogynecology and Reconstructive Pelvic Surgery Exam

200

Multiple-Choice Questions (QE)

ABOG Qualifying Exam at Pearson VUE

21%

Incontinence Blueprint Weight

Largest domain on ABOG URPS Blueprint

$2,195

2026 QE Application Fee

ABOG Subspecialty Qualifying Exam

2 boards

Joint ABOG + ABU Sponsorship

OB-GYN and Urology subspecialty

2024

FPMRS Renamed to URPS

Effective January 1, 2024

July 20, 2026

QE Exam Date

ABOG 2026 subspecialty schedule

ABOG URPS (formerly FPMRS) is a two-step jointly-sponsored (ABOG/ABU) subspecialty certification: a ~4-hour computer-based Qualifying Exam (single-best-answer MCQs at Pearson VUE on July 20, 2026) followed by an oral Certifying Examination in Dallas. The ABOG URPS Blueprint weights Urinary Incontinence and LUTS 21%, Pelvic Organ Prolapse 18%, General Perioperative Management 13%, Fecal Incontinence and Defecation 9%, Urinary Tract Injury 8%, UTI and Hematuria 8%, Application of Anatomy 8%, Congenital Anomalies 7%, Core Competencies 5%, and Urethral Mass 3%. 2026 QE fee is $2,195; CE fee is $1,275. First-time pass rates run ~85-92%.

Sample ABOG Urogynecology and Reconstructive Pelvic Surgery Practice Questions

Try these sample questions to test your ABOG Urogynecology and Reconstructive Pelvic Surgery exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 58-year-old postmenopausal woman presents with urinary leakage with coughing, laughing, and exercise. She has no urgency symptoms. Urinalysis is normal, PVR is 30 mL. What is the most likely diagnosis?

A.Overactive bladder with urgency urinary incontinence

B.Stress urinary incontinence

C.Overflow incontinence

D.Functional incontinence

Explanation: Stress urinary incontinence (SUI) is involuntary leakage with effort/exertion (cough, laugh, exercise) due to urethral hypermobility and/or intrinsic sphincter deficiency (ISD). Urge urinary incontinence has urgency as primary symptom. Mixed UI combines both. Overflow incontinence has elevated PVR. Workup: history, exam, cough stress test, PVR, urinalysis. Urodynamics not routinely needed for uncomplicated SUI before primary surgery (VALUE trial).

2A 62-year-old woman with bothersome stress urinary incontinence has failed pelvic floor physical therapy and desires surgical treatment. Which procedure has level-1 evidence as first-line surgical treatment for SUI?

A.Retropubic Burch colposuspension

B.Midurethral sling (retropubic TVT or transobturator TOT) — level-1 evidence as first-line; cure rates ~85%; SISTEr trial showed equivalence to autologous fascial sling; TOMUS compared TVT vs TOT

C.Urethral bulking agents

D.Autologous fascial sling

Explanation: Midurethral sling (MUS) has level-1 evidence as first-line surgical therapy for SUI. Retropubic (TVT — tension-free vaginal tape) and transobturator (TOT) approaches both effective. TOMUS trial (Richter 2010): comparable cure rates (~81% TOT, 78% TVT). TVT has higher bladder perforation risk (~5% vs <1%). TOT has higher groin pain. TVT generally preferred for ISD. Retropubic Burch is alternative. Autologous fascial sling (SISTEr trial) reserved for mesh contraindication or recurrent SUI. Urethral bulking for selected patients (ISD, elderly, comorbid).

3A 55-year-old woman has urgency urinary incontinence refractory to anticholinergics and mirabegron. Which 3rd-line therapy is FDA-approved for OAB?

A.Onabotulinumtoxin A 100 U intradetrusor injection via cystoscopy — 20 injections of 0.5 mL (5 U each) across bladder body, sparing trigone; duration ~6-9 months; main adverse effects UTI and urinary retention requiring CIC (~6-10%)

B.Oral imipramine

C.Topical testosterone

D.Oral vasopressin

Explanation: OAB treatment hierarchy: 1st-line behavioral therapy (bladder training, fluid management, pelvic floor exercises); 2nd-line pharmacologic (anticholinergics — oxybutynin, tolterodine, solifenacin, darifenacin; beta-3 agonist — mirabegron, vibegron; combination); 3rd-line advanced therapies. OnabotulinumtoxinA 100 U intradetrusor injection via cystoscopy: 20 sites, 0.5 mL each, 5 U per site across bladder body. Duration 6-9 months typically. Adverse effects: UTI, urinary retention requiring CIC (~6-10%) — counsel prior. Alternative 3rd-line: sacral neuromodulation (InterStim), PTNS (posterior tibial nerve stimulation).

4A 70-year-old presents for evaluation with a vaginal bulge. POP-Q measurements at the leading edge are: Aa +2, Ba +4, C +5. What is the POP-Q stage of anterior compartment prolapse?

A.Stage 0 — no prolapse

B.Stage I — leading edge >1 cm above hymen

C.Stage II — leading edge within 1 cm of hymen (-1 to +1)

D.Stage III — leading edge >1 cm below hymen but less than TVL-2

Explanation: POP-Q staging by leading edge position (most distal point): Stage 0 = no prolapse (Aa/Ba at -3, C at -TVL); Stage I = leading edge >1 cm above hymen; Stage II = leading edge -1 to +1 (within 1 cm of hymen); Stage III = leading edge >1 cm below hymen BUT NOT complete eversion (TVL -2); Stage IV = complete eversion (≥ TVL -2). With Ba +4 (leading point anteriorly), this is stage III (beyond 1 cm below hymen but not complete eversion if TVL is 9 cm or greater).

5A 58-year-old has symptomatic stage III uterovaginal prolapse and desires definitive surgical treatment with preservation of sexual function. Which surgical procedure is gold standard for apical vaginal vault support?

A.Anterior colporrhaphy alone

B.Abdominal sacrocolpopexy (mesh sling from vaginal vault to sacrum) — gold standard for apical POP repair with highest long-term anatomical success rates (~90%); can be performed open, laparoscopic, or robotic

C.Colpocleisis

D.Posterior colporrhaphy alone

Explanation: Abdominal sacrocolpopexy is gold standard for apical POP repair: Y-shaped mesh from anterior and posterior vaginal walls anchored to anterior longitudinal ligament of sacrum. Long-term anatomical success ~90% at 7 years (CARE trial). Open, laparoscopic, or robotic approaches — MIS preferred for shorter recovery. Lower recurrence than vaginal apical procedures (USLS, SSLF) but higher mesh complication risk (~2-10% mesh exposure). Consider concurrent anti-incontinence procedure (CARE trial showed Burch reduces post-op SUI). Colpocleisis (obliterative) reserved for women not sexually active with high surgical risk.

6During laparoscopic sacrocolpopexy, in which anatomic structure is the mesh typically attached for apical support?

A.Cooper's ligament

B.Anterior longitudinal ligament of the sacrum at the S1-S2 level (or sacral promontory area) — provides strong fixation; careful to avoid middle sacral artery injury

C.Arcus tendineus fasciae pelvis

D.Uterosacral ligaments

Explanation: Sacrocolpopexy mesh anchored to anterior longitudinal ligament of sacrum at S1-S2 level (not promontory itself — too vascular with middle sacral artery). Avoid left common iliac vein (crosses at L5 level, to left of midline) and middle sacral artery. Mesh runs along posterior cul-de-sac without tension. Alternative Y-mesh fixation to anterior and posterior vaginal walls. Common complications: mesh erosion into vagina or bladder, bowel injury, ureteral injury, mesh infection. Y-mesh of polypropylene Type 1 (macroporous, monofilament) associated with lowest complication rates.

7A 65-year-old with a prior hysterectomy has a stage III vaginal vault prolapse with leading edge 3 cm below hymen. She is medically complex (age 80, CHF, moderate frailty). She and her husband are not sexually active. Which procedure may be best?

A.Abdominal sacrocolpopexy

B.Colpocleisis (obliterative procedure — LeFort or total) — shorter OR time, lower morbidity, high success rates (~95%), acceptable for women not sexually active; denudes vaginal epithelium and partial/complete obliteration of vaginal canal

C.Vaginal hysterectomy (she has already had hysterectomy)

D.Tension-free sacrospinous ligament fixation

Explanation: Colpocleisis (obliterative procedure) for post-hysterectomy vault prolapse in women not sexually active with high surgical risk: LeFort (partial, preserves lateral channels for cervical drainage) or total colpocleisis (obliterates entire vagina). Advantages: short OR time (60-90 min), can be done under regional/local anesthesia, high success rate (95%+), low morbidity. Disadvantages: eliminates vaginal intercourse (must counsel extensively). Concurrent anti-incontinence procedure if SUI symptoms. Contraindication: uterine pathology if uterus present, desire for sexual function.

8A 55-year-old with mixed urinary incontinence (SUI + UUI) is being counseled about treatment. Which approach is appropriate?

A.Address the MOST bothersome symptom first — often start with conservative measures (pelvic floor PT, behavioral), treat OAB medically if urgency predominant, or surgical sling if SUI predominant; counsel that sling may worsen urgency in 10-20% while improving SUI; patient preference drives sequencing

B.Mandatory sling first

C.OAB medication alone for all mixed UI

D.Immediate bulking agent

Explanation: Mixed UI management: identify which symptom is MORE bothersome. Common approach: conservative (pelvic floor PT, bladder training, behavioral) first-line for all. If SUI predominant: midurethral sling — may improve BOTH components (~60-70% of mixed UI patients report urgency improvement post-sling) but may worsen urgency in 10-20% (de novo urgency). If UUI predominant: treat OAB first (antimuscarinic or mirabegron), reassess for residual SUI. Counsel about expectations. MsUD (Modified Urinary Distress Index) can quantify bother. Consider urodynamics if planning invasive intervention and findings would change treatment.

9In DeLancey's 3 levels of pelvic support, which structure provides apical (level I) support?

A.Perineal body and membrane

B.Arcus tendineus fasciae pelvis

C.Cardinal and uterosacral ligaments

D.Levator ani muscle complex

Explanation: DeLancey's 3 levels of pelvic support: Level I — apical support from cardinal and uterosacral ligaments (attach cervix and upper vagina to pelvic sidewalls); failure = apical/uterine prolapse. Level II — lateral/mid-vaginal support from endopelvic fascia attaching to arcus tendineus fasciae pelvis (ATFP); failure = cystocele, rectocele (anterior/posterior wall). Level III — distal vaginal support from fusion with perineal body and membrane; failure = distal rectocele, urethrocele. Understanding levels guides surgical repair targeting defect location.

10Which anatomic landmark does the ureter CROSS when entering the pelvis?

A.Pudendal canal

B.Common iliac artery at the pelvic brim (approximately at the bifurcation of common iliac into external and internal iliac arteries)

C.Inferior mesenteric artery

D.Renal artery

Explanation: Ureter anatomy: passes over/crosses common iliac vessels at the pelvic brim (bifurcation point of common iliac into external and internal). Then courses medially along pelvic sidewall attached to peritoneum (retroperitoneal). Passes UNDER uterine artery at level of cervix ('water under the bridge' — bridge = uterine artery). Enters bladder at trigone. Key surgical landmarks to avoid injury during gynecologic surgery: identify ureter at pelvic brim, trace through pelvic sidewall, verify before securing uterine vessels. Blood supply: renal artery (upper), aorta and iliac branches (middle), vesical arteries (distal).

About the ABOG Urogynecology and Reconstructive Pelvic Surgery Exam

The ABOG Urogynecology and Reconstructive Pelvic Surgery (URPS) subspecialty certification — formerly known as Female Pelvic Medicine and Reconstructive Surgery (FPMRS) through 2023 — is a two-step process jointly sponsored by the American Board of Obstetrics and Gynecology and the American Board of Urology. Step 1 is the Qualifying Examination, a computer-based multiple-choice written exam at Pearson VUE administered on July 20, 2026. Step 2 is the Certifying Examination, an oral exam in Dallas that includes thesis defense, case-list review, and structured cases. Candidates must complete an ACGME-accredited URPS fellowship, hold primary ABOG or ABU board certification, defend a thesis, and maintain active licensure. The QE content follows the ABOG URPS Qualifying Exam Blueprint.

Questions

200 scored questions

Time Limit

Approximately 4 hours (computer-based Qualifying Exam)

Passing Score

Criterion-referenced scaled passing standard (ABOG/ABU URPS Division, modified Angoff)

Exam Fee

$2,195 QE application + $1,275 CE fee (ABOG 2026) (American Board of Obstetrics and Gynecology (ABOG) — jointly sponsored with the American Board of Urology (ABU); Division of Urogynecology and Reconstructive Pelvic Surgery)

ABOG Urogynecology and Reconstructive Pelvic Surgery Exam Content Outline

21%

Urinary Incontinence and Lower Urinary Tract Symptoms

Diagnosis and differentiation of SUI, urgency UI, mixed UI, and OAB; POP-Q exam; myofascial pelvic exam; initial workup (pad test, PVR, urinalysis, cough stress test, voiding diary); advanced testing (multichannel urodynamics, cystoscopy); non-surgical treatment (pelvic floor PT, anticholinergics/mirabegron, urethral bulking, onabotulinumtoxinA 100 U for OAB, PTNS, pessaries); surgical treatment (retropubic Burch, midurethral sling — level-1 evidence first-line for SUI, autologous fascial sling, sacral neuromodulation).

18%

Pelvic Organ Prolapse

POP-Q staging (stage 0-IV based on leading edge relative to hymen), compartment-specific evaluation (anterior, apical, posterior), non-surgical options (pelvic floor PT, pessary fitting and care), surgical options — vaginal (hysterectomy ± USLS/SSLF, anterior/posterior colporrhaphy, colpocleisis/obliterative procedures), abdominal/laparoscopic/robotic sacrocolpopexy (gold standard for apical support with mesh), hysteropexy, mesh/graft augmented repairs, complications (mesh exposure/erosion, dyspareunia, recurrent prolapse).

13%

General Perioperative Management

Preoperative testing by comorbidity (cardiovascular, diabetes, immunosuppression, geriatric), VTE prophylaxis (mechanical + pharmacologic based on Caprini score), perioperative anticoagulation management, ERAS protocols, positioning to avoid nerve injury (femoral, peroneal, sciatic from lithotomy; brachial plexus from Trendelenburg), intraoperative techniques to minimize injury (ureter identification, bladder back-fill, intraoperative cystoscopy), management of intraoperative vascular/bowel/urinary/nerve injuries, prolonged catheterization management.

Fecal Incontinence and Defecation Disorders

Diagnosis of FI types (passive, urge, overflow); pelvic floor ultrasound and endoanal ultrasound for sphincter defects; anorectal manometry; defecography; colonoscopy; non-surgical treatments (dietary modification, antidiarrheals, biofeedback and pelvic floor PT, bulking agents); surgical options (sacral neuromodulation — level-1 evidence for FI, rectovaginal fistula repair, overlapping anal sphincteroplasty for traumatic OASIS, transvaginal repair); management of obstructed defecation and rectoceles.

Urinary Tract Injury

Bladder injury diagnosis (cystoscopy, CT urogram, retrograde pyelogram, voiding cystourethrogram); bladder repair techniques (two-layer cystotomy closure, vesicovaginal fistula repair — vaginal Latzko, transabdominal O'Conor, MIS); ureteral injury (diagnosis with cystoscopy and retrograde pyelogram; treatment with stent, ureteroneocystostomy, Boari flap, psoas hitch, ureteroureterostomy); urethral injury and urethrovaginal fistula repair with Martius labial fat pad flap as interposition graft.

Urinary Tract Infection and Hematuria

Diagnosis and management of acute uncomplicated UTI, recurrent UTI (3+ per year or 2 in 6 months — AUA/SUFU guideline: prophylactic antibiotics, vaginal estrogen in postmenopausal women, methenamine hippurate, d-mannose, cranberry), complicated UTI, urogenital atrophy management with vaginal estrogen; hematuria workup — microscopic hematuria (≥3 RBC/HPF) requires evaluation per AUA guidelines (CTU + cystoscopy for high-risk), gross hematuria always requires cystoscopy and upper tract imaging.

Application of Anatomy to Patient Care

Vascular supply (uterine, vaginal, pudendal, inferior epigastric), nerve supply (ilioinguinal, iliohypogastric, genitofemoral, pudendal, obturator), bladder and urethra anatomy, levels of pelvic support (DeLancey level I: cardinal-uterosacral apical; level II: paravaginal/arcus tendineus; level III: perineal body), ureter course (crosses iliac vessels at pelvic brim, passes under uterine artery 'water under the bridge'), anal sphincter complex, rectum and colon, central/peripheral nervous system applications to pelvic floor dysfunction.

Congenital Anomalies of the Urogenital Tract

Diagnosis and workup of Müllerian anomalies (ASRM 2021 classification: septate, bicornuate, unicornuate, didelphys, MRKH — Mayer-Rokitansky-Küster-Hauser) with imaging (ultrasound, MRI), karyotype, and hormone testing; non-surgical management (expectant management, vaginal dilation as first-line per Frank and Ingram methods); neovagina surgical procedures (McIndoe split-thickness skin graft, laparoscopic Vecchietti, laparoscopic Davydov peritoneal flap); septum resection; management of post-surgical complications.

Core Competencies and Cross Content

Ethics and professionalism (health disparities, shared decision making, psychosocial considerations), patient safety (root cause analysis, procedural time-outs, sentinel event review, ERAS bundles/checklists), interpersonal communication with diverse patients and disclosure of adverse outcomes, systems-based practice (cost awareness, multidisciplinary teams), practice-based learning, evidence-based medicine, quality improvement.

Urethral Mass

Diagnosis and differentiation of urethral masses (urethral diverticulum — most common, leiomyoma, caruncle, prolapse, malignancy); imaging (pelvic floor ultrasound, MRI — T2 hyperintense for diverticulum), cystoscopy and biopsy; treatment options (observation, drainage, marsupialization for caruncle, excision with urethral reconstruction, concomitant anti-incontinence procedure with autologous sling — not mesh — if concurrent SUI); management of complications.

How to Pass the ABOG Urogynecology and Reconstructive Pelvic Surgery Exam

What You Need to Know

Passing score: Criterion-referenced scaled passing standard (ABOG/ABU URPS Division, modified Angoff)
Exam length: 200 questions
Time limit: Approximately 4 hours (computer-based Qualifying Exam)
Exam fee: $2,195 QE application + $1,275 CE fee (ABOG 2026)

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

ABOG Urogynecology and Reconstructive Pelvic Surgery Study Tips from Top Performers

1Memorize POP-Q staging: Stage 0 = no prolapse (Aa/Ap/Ba/Bp at -3, C/D at total vaginal length); Stage I = leading edge >1 cm above hymen; Stage II = leading edge within 1 cm of hymen (-1 to +1); Stage III = leading edge >1 cm below hymen but NOT complete eversion; Stage IV = complete vaginal eversion

2Know that midurethral sling has level-1 evidence as first-line surgical treatment for stress urinary incontinence (both retropubic TVT and transobturator TOT approaches); retropubic has higher efficacy for intrinsic sphincter deficiency but higher bladder perforation risk (~5% vs <1%); TOT has higher groin pain but lower voiding dysfunction — counsel on both options

3Master DeLancey's 3 levels of pelvic support: Level I — cardinal and uterosacral ligaments provide apical/upper vaginal support (failure = apical prolapse); Level II — paravaginal attachments to arcus tendineus fasciae pelvis (failure = anterior/cystocele); Level III — perineal body and membrane fuse vagina to adjacent structures (failure = distal rectocele, urethrocele)

4Learn the approach to urodynamics interpretation: detrusor overactivity = involuntary detrusor contraction during filling; stress urinary incontinence by urodynamics = leakage with Valsalva/cough in absence of detrusor contraction; Valsalva leak point pressure <60 cm H2O suggests intrinsic sphincter deficiency; functional profile length and maximum urethral closure pressure help characterize ISD

5Know onabotulinumtoxinA 100 U intradetrusor injection for refractory OAB (20 injections of 0.5 mL each, 5 U per site across bladder body, avoiding trigone) — clinical effect 6-9 months, main adverse effects are UTI and urinary retention requiring CIC in ~6% (counsel before procedure); sacral neuromodulation (InterStim) is alternative level-1 therapy for refractory OAB and non-obstructive urinary retention

Frequently Asked Questions

What is the ABOG Urogynecology and Reconstructive Pelvic Surgery subspecialty exam?

ABOG URPS certification (formerly FPMRS from 2013 through 2023) is a two-step voluntary subspecialty credential jointly sponsored by the American Board of Obstetrics and Gynecology and the American Board of Urology. Step 1 is the Qualifying Examination (QE), a computer-based multiple-choice written exam at Pearson VUE. Step 2 is the Certifying Examination (CE), an oral exam at the ABOG National Center in Dallas. Starting January 1, 2024, ABOG and ABU renamed the subspecialty from FPMRS to URPS. OB-GYN candidates apply through ABOG; urology candidates apply through ABU, with exam content largely aligned.

How many questions are on the ABOG URPS Qualifying Exam and how long is it?

The URPS Qualifying Exam is a computer-based single-best-answer multiple-choice exam delivered at Pearson VUE over approximately 4 hours. The published ABOG URPS Blueprint weights Urinary Incontinence and LUTS at 21%, Pelvic Organ Prolapse at 18%, General Perioperative Management at 13%, Fecal Incontinence/Defecation at 9%, Urinary Tract Injury at 8%, UTI and Hematuria at 8%, Application of Anatomy at 8%, Congenital Anomalies at 7%, Core Competencies at 5%, and Urethral Mass at 3%.

What is the passing score for the ABOG URPS exam?

Both the Qualifying and Certifying Examinations use criterion-referenced scaled passing standards set by the joint ABOG/ABU URPS Division through a modified Angoff standard-setting process. Scores are not curved against peers — candidates are measured against a content-expert performance standard. Reports include pass/fail plus diagnostic performance by content domain. Historical first-time URPS/FPMRS QE pass rates run approximately 85-92% per the ABOG public pass-rate tool.

What are the eligibility requirements for ABOG URPS certification?

OB-GYN candidates must (1) hold active primary ABOG Specialty (OB-GYN) certification; (2) complete an ACGME-accredited URPS fellowship (3 years); (3) successfully defend an approved thesis before applying for the CE; (4) submit a compliant case list; and (5) maintain active, unrestricted medical licensure. Urology candidates apply through ABU after completing a 24-month ACGME URPS fellowship and holding active ABU certification. All candidates take content drawn from the jointly-developed URPS blueprint.

How much does the ABOG URPS exam cost?

For 2026, the Subspecialty Qualifying Examination fee is $2,195 when applied for by February 15, 2026, with a $400 late fee if applied March 15 or earlier. The Certifying Examination fee is $1,275 when submitted July 1-31, 2026, with a $400 late fee for August submissions. CE application fee is additional ($1,125 on-time). These fees are set by ABOG and apply across all subspecialties. ABU candidates pay fees set by ABU.

When was FPMRS renamed to URPS?

Effective January 1, 2024, ABOG and ABU officially renamed the jointly-sponsored subspecialty from Female Pelvic Medicine and Reconstructive Surgery (FPMRS) to Urogynecology and Reconstructive Pelvic Surgery (URPS). FPMRS certificates were issued from 2013 through 2023; all new certificates issued after January 1, 2024, use the URPS designation. Candidates who passed the 2024 Certifying Exams received URPS certificates. Current FPMRS diplomates can request a replacement certificate showing URPS. The rename does not change scope of practice — it aligns terminology with the broader urogynecology field.

What are the highest-yield topics on the ABOG URPS exam?

High-yield topics include POP-Q staging (stages 0-IV relative to the hymen), midurethral sling as level-1 evidence first-line for SUI with retropubic vs transobturator trade-offs (TVT has higher efficacy for intrinsic sphincter deficiency, TOT lower bladder perforation risk), sacrocolpopexy as gold standard for apical POP repair, sacral neuromodulation for refractory OAB and FI, DeLancey levels of pelvic support (level I apical, II lateral, III distal), vesicovaginal fistula repair approaches (Latzko vaginal, O'Conor transabdominal), onabotulinumtoxinA 100 U for OAB, recurrent UTI management per AUA/SUFU guideline (vaginal estrogen postmenopausal, methenamine hippurate, prophylactic antibiotics), and Müllerian anomaly classification with vaginal dilation as first-line for MRKH.

How should I study for the ABOG URPS exam?

Use the ABOG URPS QE Blueprint as your master syllabus, distributing study time by domain weight (incontinence 21%, POP 18%, perioperative 13%, fecal incontinence 9%, UT injury 8%, UTI/hematuria 8%, anatomy 8%, congenital anomalies 7%, core competencies 5%, urethral mass 3%). Master AUGS practice bulletins, ACOG committee opinions, AUA/SUFU guidelines, and the URPS Guide to Learning. Focus on POP-Q staging, midurethral sling outcomes, sacrocolpopexy, urodynamic interpretation, fistula repair approaches, FDA pelvic mesh history, and Müllerian anomaly classification. Review research methods and biostatistics for CE thesis defense.